Holen Sie sich die Stockscreener-App
328.20
0.15%
-0.49
Handel nachbörslich:
328.20
Penumbra Inc Aktie (PEN) Neueste Nachrichten
Penumbra, Inc. (PEN) Stock Analysis: A Healthcare Giant With A 10.55% Upside Potential - DirectorsTalk Interviews
Water Island Event-Driven Fund's Penumbra Inc(PEN) Holding History - GuruFocus
Penumbra stock hits 52-week high at $328.69 By Investing.com - Investing.com Australia
Penumbra stock hits 52-week high at $328.69 - Investing.com
Penumbra (PEN) CEO-linked trust donates 77,000 shares in charitable stock gift - Stock Titan
Peripheral Embolization Coils Market is experiencing boost - openPR.com
PEN Stock Price, Quote & Chart | PENUMBRA INC (NYSE:PEN) - ChartMill
(PEN) Movement as an Input in Quant Signal Sets - Stock Traders Daily
ServisFirst Gets Axed by Champlain — a Minor Position in a Major Drawdown - The Motley Fool
HBK INVESTMENTS L P's Penumbra Inc(PEN) Holding History - GuruFocus
120,815 Shares in Penumbra, Inc. $PEN Purchased by Stephens Investment Management Group LLC - MarketBeat
Thrivent Financial for Lutherans Sells 72,330 Shares of Penumbra, Inc. $PEN - MarketBeat
Penumbra, Inc. (NYSE:PEN) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Penumbra, Inc. (PEN) Stock Analysis: Navigating a 12.76% Upside in the Medical Devices Sector - DirectorsTalk Interviews
Penumbra, Inc. Reports Third Quarter 2025 Financial Results - Quantisnow
Penumbra Shareholders Approve Merger with Boston Scientific - The Globe and Mail
Penumbra revenue up 15.6% to USD 374.8M in Q1 2026 - Medical Buyer
PEN Maintained by Citigroup -- Price Target Lowered to $350 - GuruFocus
Citi Maintains Penumbra(PEN.US) With Hold Rating, Cuts Target Price to $350 - Moomoo
Penumbra Is Maintained at Outperform by Evercore ISI Group - Moomoo
Liquidity Mapping Around (PEN) Price Events - Stock Traders Daily
PEN Maintained by Evercore ISI Group -- Price Target Lowered to $335 - GuruFocus
Penumbra Is a 'Strong' Strategic Fit for Boston Scientific, RBC Says - Moomoo
Penumbra shareholders approve merger with Boston Scientific By Investing.com - Investing.com Australia
Penumbra, Inc. Q1 2026 Financial Results: Earnings, Comprehensive Income, and Stockholders’ Equity Highlights - Minichart
Penumbra IncStockholders approve merger with Boston ScientificSEC filing - marketscreener.com
Penumbra shareholders approve merger with Boston Scientific - Investing.com
Penumbra (NYSE: PEN) shareholders approve Merger Proposal; closing conditions remain - Stock Titan
Penumbra (NYSE: PEN) investors back merger, await antitrust approvals - Stock Titan
Evercore Maintains Penumbra(PEN.US) With Buy Rating, Cuts Target Price to $335 - Moomoo
Penumbra: Q1 Earnings Snapshot - theheraldreview.com
Assessing Penumbra (PEN) Valuation As Growth Expectations Meet A Premium P/E Multiple - Yahoo Finance
Penumbra Shareholder Notice - TMX Newsfile
MSN Money - MSN
Penumbra (PEN) Misses Q1 Earnings Estimates - Yahoo Finance
[10-Q] Penumbra Inc Quarterly Earnings Report - Stock Titan
Earnings Flash (PEN) Penumbra, Inc. Reports Q1 Revenue $374.8M, vs. FactSet Est of $371.3M - marketscreener.com
Penumbra (NYSE: PEN) posts $374.8M Q1 2026 revenue as Boston Scientific deal looms - Stock Titan
Penumbra posts $32.6M profit as Boston Scientific deal halts outlook - Stock Titan
Penumbra, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
PEN Technical Analysis | Trend, Signals & Chart Patterns | PENUMBRA INC (NYSE:PEN) - ChartMill
Penumbra earnings in focus as Boston Scientific deal looms By Investing.com - Investing.com South Africa
Penumbra earnings in focus as Boston Scientific deal looms - Investing.com
Penumbra, Inc. (PEN) Stock Analysis: A 12.44% Potential Upside in the Thriving Medical Devices Sector - DirectorsTalk Interviews
Vanguard Group Inc. Cuts Stock Position in Penumbra, Inc. $PEN - MarketBeat
Inside Boston Scientific's $15 billion offer for Alameda's largest employer - The Business Journals
1.27%
2.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):